InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Raymon Heather. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. In total, 6 reports have been recorded. Activity tracked since 12 September 2024. The latest transaction was disclosed on 15 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Raymon Heather is SVP, Research and Development at Artiva Biotherapeutics, Inc. The declarant has 6 filings in total, and across the 6 recent filings available, the transactions are of Attribution nature, with a date range from 2024-09-13 to 2026-02-18.